Related Experiment Videos
Hypothyroidism and depression: a therapeutic challenge
1Department of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, Morgantown 26505, USA. srack@hsc.wvu.edu
The Annals of Pharmacotherapy
|October 31, 2000
Summary
Adding triiodothyronine (T3) to thyroxine (T4) therapy significantly improved mood in a patient with long-standing depression and hypothyroidism. This suggests T3 may be crucial for treating depression linked to thyroid issues.
Area of Science:
- Endocrinology
- Psychiatry
- Pharmacology
Background:
- Hypothyroidism is a known contributor to depression.
- Standard thyroxine (T4) replacement therapy may not fully resolve depressive symptoms in all hypothyroid patients.
Observation:
- A 50-year-old woman with a history of depression and hypothyroidism showed persistent symptoms despite high-dose T4 treatment.
- Thyroid-stimulating hormone levels remained elevated, indicating inadequate thyroid hormone replacement.
Findings:
- Addition of a low dose of triiodothyronine (T3) to her T4 regimen led to significant mood improvement.
- This case suggests T3 may be more effective than T4 alone for treating depression associated with hypothyroidism.
Implications:
- Depressed patients should be screened for hypothyroidism.
- Consider T3 inclusion in thyroid hormone replacement therapy for hypothyroid patients with refractory depression.
- T3 may be a superior adjuvant therapy for unipolar depression compared to T4 alone.